Yahya Tawfik: Rising Iron Deficiency in the US – 10 Million More Adults Affected Since 1999
Yahya Tawfik, Assistant Professor at King Saud University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in The American Journal of Medicine, adding:
“Excited to share our latest work ‘Temporal Trends in Absolute Iron Deficiency Among US Adults.’
Iron deficiency isn’t just about anemia.
Even without anemia, it’s been linked to impaired physical function, neurocognitive problems, heart failure, and mortality.
Yet how its prevalence has changed over time in the US hasn’t been well defined.
Using NHANES data, we compared 1999–2002 with 2017–2020:
- Age- and sex-adjusted prevalence of absolute iron deficiency rose from 11.2% to 14.2%
- That’s roughly 22.8 million to 32.3 million US adults
- The biggest increase was in women aged 18–50, up 6.4%
These results raise important questions about what’s driving the rise and how we can better identify those affected before it impacts their health.
Grateful to work alongside lman Aboelsaad, Michael D. Nelson, Hsin-Jun Yang, and Leo Buckley on this one.”
Title: Temporal Trends in Absolute Iron Deficiency Among US Adults
Authors: Yahya MK Tawfik, Iman AF Aboelsaad, Michael D Nelson, Hsin-Jun Yang, Leo F Buckley

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series